Tyler McFadden | March 20, 2019

TRENTON, NJ — In some big news out of New Jersey, several marijuana reform bills have been voted out of their committees and are awaiting floor votes.

Senate Bill 2703 and Assembly Bill 4497 have both passed out of their committees and are set to be voted on as early as Monday, March 25th.

These bills would legalize the personal possession of one ounce or less of cannabis and would regulate and tax the adult-use and retail sale. Some highlights of this landmark legislation are-

• Expedited expungement of past misdemeanor marijuana convictions
• Taxing marijuana sales at three-percent, which will be collected by or paid to municipalities wherever retail stores exist
• Incentives to promote socio-economic, racial, and gender equity in the state’s cannabis industry

Governor Phil Murphy, one of the driving forces of marijuana legalization in the state since taking office in 2018, has already signaled his intent to sign a legalization bill once it gets to his desk.

However, the margins in the New Jersey State Legislature are still very close, with a slight majority of the legislators being in favor of legalizing marijuana for adult-use in the state.

With several state lawmakers still on the fence about legalization, input from residents of New Jersey is of paramount importance. Legalizing marijuana would result in dozens of positive impacts for New Jerseyans and cannot happen without the support of reform-minded residents who are committed to personal freedom in New Jersey.

Are you a New Jersey resident? Click here to send a message to your legislators in support of legalizing marijuana in the Garden State.

Other legislation, Senate Bill 3205 and Assembly Bill 4498 have both passed out of their committees and are awaiting scheduled votes. These bills would allow for the expedited expungement of certain marijuana-related convictions after marijuana legalization is signed into law in New Jersey. It reduces the wait time for expungement and expands the list of convictions eligible for expungement upon marijuana legalization in the state.

Separate legislation, Senate Bill 10 and Assembly Bill 10 have both passed out of their committees and are awaiting scheduled votes. These bills would expand the state’s medical marijuana program to allow for greater accessibility and protections for qualified patients. It increases the amount of medical cannabis a qualified patient is legally allowed to purchase and possess, protects patients from losing their jobs or custody of their children simply because of their status as a medical patient, and phases out retail sales taxes on medical marijuana to make the program more affordable for patients.

Tags: 2019 Legislation, New Jersey marijuana legalization, New Jersey medical marijuana, NJ AB 4497, NJ AB 4498, NJ SB 10, NJ SB 2703, NJ SB 3205, Phil Murphy

Paul Armentano | March 20, 2019

A widely reported study appearing today in the British journal The Lancet alleges that an estimated 30 to 50 percent of psychosis cases in Europe are due to cannabis exposure, and that exposure to elevated levels of THC increases this risk.

NORML has previously written on the data showing a multi-directional association between cannabis and psychiatric illnesses, and we have cautioned that those predisposed to psychosis or other disorders may be at higher risk for adverse events.

That said, it remains premature at best, and sensational at worst to claim that a causal relationship exists between marijuana use and psychiatric disorders on the basis of this new paper. That is because, by the observational nature of its design, this study at best can only demonstrate a correlation.

Nonetheless, despite this limitation, the authors boldly “assume causality.” Given the fact that such a cause-and-effect relationship remains unproven and there as of yet exists no consensus among experts that such causation exists, their assumption is, at best, highly questionable.

Moreover, it is well established that those with psychiatric illness typically use all intoxicants at greater rates than do the general public, so the fact that those admitted to institutions for first-episode psychosis are more likely to consume cannabis than are those in the general population is hardly surprising. But it is not evidence that marijuana in any way causes the condition. Rather, this association may exist because many psychiatric patients are self-medicating with cannabis. Or, this relationship may persist because many people predisposed to psychosis are similarly predisposed to also using cannabis — a theory that is supported by many experts in the field.

Perhaps most importantly, the fact that cannabis has been used by various populations for decades at disparate rates, yet rates of psychosis and other psychiatric disorders have generally remained static over this same period of time, strongly argues against a direct causal relationship.

Finally, authors’ presumptions specific to the supposed disparate effects of cannabis based upon THC potency are also highly questionable. This is because subjects in the study self-reported their cannabis use. As a result, authors had no ability to verify the THC content of the marijuana consumed by participants. Further, the cannabis consumed by subjects in the study was largely obtained via black market channels — leaving the users equally in the dark with regard to its actual cannabinoid content.

Nonetheless, despite these limitations, the concerns raised in this paper and others ought to be taken seriously, and they provide an argument in favor of greater regulation of the plant so that it can be better kept out of the hands of young people and those who may be at higher risk for an adverse reaction. But maintaining cannabis prohibition, unfortunately, achieves neither result. Placed in this context, these latest scare-mongering claims — even if taken at face value — do little to advance arguments in favor of tightening prohibition, and provides ample ammunition to wage for its repeal.

Tags: psychiatric illness, psychosis

Podcast: Play in new window | Download

Subscribe: Apple Podcasts | Android |

Marijuana Today Daily Headlines
Thursday, August 8, 2019 | Curated by host Shea Gunther

// Bernie Sanders Wouldn’t Legalize Drugs Other Than Marijuana, He Tells Joe Rogan (Marijuana Moment)

// Marijuana-infused product brand Dixie inks licensing deal with Arizona Iced Tea maker (Marijuana Business Daily)

// One-In-Seven Americans Use CBD, According To A New Gallup Survey (Marijuana Moment)

---

These headlines are brought to you by Curaleaf, one of the leading vertically-integrated cannabis operators in the U.S. With legal medical marijuana dispensaries, cultivation sites, and processing facilities all over the United States, Curaleaf has served more than 100,000 medical cannabis patients and looks forward to helping many more long into the future. Swing over to Curaleaf.com to learn more about this very cool company!

---

// California OKs cannabis sales and use at San Francisco’s Outside Lands music festival (LA Times)

// ‘Growing outside is a dream’: Asparagus makes way for cannabis in Canada’s fields (Financial Post)

// Young Living vs. doTERRA: Utah MLM Companies and the CBD Race (Canna Law Blog)

// TGOD Files To List On NASDAQ (Green Market Report)

// Attorney suing OMMA, DPS says potential of police accessing medical marijuana patient data ‘brands’ cardholders with a ‘scarlet letter’ (Tulsa World)

// Hair Follicle Tests Produce More False Positives for Black People, NAACP Says (Merry Jane)

// More Than 150 Proposed SXSW Marijuana Panels Are Being Voted On For Next Year’s Festival (Marijuana Moment)

---

Check out our other projects:
• Marijuana Today— Our flagship title, a weekly podcast examining the world of marijuana business and activism with some of the smartest people in the industry and movement.
• Marijuana Media Connect— A service that connects industry insiders in the legal marijuana industry with journalists, bloggers, and writers in need of expert sources for their stories.

Love these headlines? Love our podcast? Support our work with a financial contribution and become a patron.

Photo: Joe Rogan podcast

2020, Arizona, Austin, Bernie Sanders, California, Canada, CBD, CBD oil, Colorado, consumption, cultivation, dispensary, drinks, drug testing, edibles, interview, investment, Joe Rogan, licensing, marketing, MLM, music, Oklahoma, outdoor, podcast, police, poll, race, racism, social use, Texas, Utah, Vermont